Chinchu J U, Mohan Mohind C, Prakash Kumar B
Inflammation Research Lab, School of Biosciences, Mahatma Gandhi University, Kottayam, India.
Arch Physiol Biochem. 2023 Dec;129(4):879-892. doi: 10.1080/13813455.2021.1877309. Epub 2021 Feb 4.
Obesity is associated with chronic low-grade inflammation, characterised by the up-regulation of pro-inflammatory cytokines in obese adipose tissue. In this study, 3T3-L1 CM enhanced TNF-α and IL-1β in RAW 264.7 cells compared with LPS treated cells. However, treatment with Varanadi kashayam suppressed the inflammatory changes associated with RAW 264.7 cells. Subsequently, RAW CM used to stimulate adipocytes, resulting in decreased intracellular lipid content and reduced adipogenic markers after Varanadi kashayam treatment. The chemical profiling of Varanadi kashayam using UHPLC-Q-Orbitrap-HRMS identified 194 compounds by comparing their retention time, the experimentally measured exact mass of precursor, and fragmented ions, and fragmentation pattern with spectral library and reported literature. Collectively, Varanadi kashayam act as a potent anti-inflammatory and anti-adipogenic agent that could disrupt the crosstalk between adipocytes and macrophages. Hence it could be a better candidate for reducing inflammation associated with obese adipose tissue.
肥胖与慢性低度炎症相关,其特征是肥胖脂肪组织中促炎细胞因子上调。在本研究中,与LPS处理的细胞相比,3T3-L1条件培养基增强了RAW 264.7细胞中的TNF-α和IL-1β。然而,瓦拉纳迪卡夏姆处理可抑制与RAW 264.7细胞相关的炎症变化。随后,RAW条件培养基用于刺激脂肪细胞,导致瓦拉纳迪卡夏姆处理后细胞内脂质含量降低和脂肪生成标志物减少。使用UHPLC-Q-Orbitrap-HRMS对瓦拉纳迪卡夏姆进行化学分析,通过比较其保留时间、实验测量的前体精确质量、碎片离子以及与光谱库和已报道文献的碎片模式,鉴定出194种化合物。总体而言,瓦拉纳迪卡夏姆作为一种有效的抗炎和抗脂肪生成剂,可能会破坏脂肪细胞与巨噬细胞之间的相互作用。因此,它可能是减轻与肥胖脂肪组织相关炎症的更好候选药物。